RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/35526483http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/35526483http://www.w3.org/2000/01/rdf-schema#comment"Bladder cancer (BC) is one of the most common malignant tumors of the urinary system worldwide. To date, immune checkpoint inhibitors (including PD-1/PD-L1) have been applied to treat patients with bladder cancer in the clinic and achieved the promising outcome. Further improvement of the anticancer efficiency of these immune therapies is crucial for bladder cancer. Our previous RNA-seq data on CBX7 (GSE185630) suggested that CBX7 might repress PD-L1 expression and PD-1 checkpoint pathway in cancer. In this study, we revealed that CBX7 downregulated the expression of POU2F2 that indirectly repressed the PD-L1 in BC cells. Depletion of CBX7 resulted in resistance to PD-1 blockade in bladder cancer. Collectively, our results suggested that the CBX7/POU2F2/PD-L1 axis plays an important role in determining the antitumor effect of PD-1 blockade in bladder cancer."xsd:string
http://purl.uniprot.org/citations/35526483http://purl.org/dc/terms/identifier"doi:10.1016/j.bbrc.2022.04.114"xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/author"Deng Y."xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/author"Jiang Y."xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/author"Liu X."xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/author"Ren J."xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/author"Ren W."xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/author"Yu H."xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/author"Xiao X."xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/author"Zhang N."xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/author"Yan B."xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/date"2022"xsd:gYear
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/name"Biochem Biophys Res Commun"xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/pages"12-18"xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/title"CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancer."xsd:string
http://purl.uniprot.org/citations/35526483http://purl.uniprot.org/core/volume"613"xsd:string
http://purl.uniprot.org/citations/35526483http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/35526483
http://purl.uniprot.org/citations/35526483http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/35526483
http://purl.uniprot.org/uniprot/#_B0QYP2-mappedCitation-35526483http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35526483
http://purl.uniprot.org/uniprot/#_P09086-mappedCitation-35526483http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35526483
http://purl.uniprot.org/uniprot/#_H0YLL6-mappedCitation-35526483http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35526483
http://purl.uniprot.org/uniprot/#_Q16624-mappedCitation-35526483http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35526483
http://purl.uniprot.org/uniprot/#_Q4PNR6-mappedCitation-35526483http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35526483
http://purl.uniprot.org/uniprot/#_Q0GN75-mappedCitation-35526483http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35526483